COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE. JPSA [Internet]. 2023 Jun. 1 [cited 2026 Sep. 21];5(1):34-4. Available from: https://ejournal3.unud.ac.id/index.php/jpsa/article/view/3426